John A. Meligeni

723 total citations
17 papers, 622 citations indexed

About

John A. Meligeni is a scholar working on Cell Biology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, John A. Meligeni has authored 17 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cell Biology, 4 papers in Pharmacology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in John A. Meligeni's work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Antifungal resistance and susceptibility (3 papers). John A. Meligeni is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (4 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Antifungal resistance and susceptibility (3 papers). John A. Meligeni collaborates with scholars based in United States, Japan and Switzerland. John A. Meligeni's co-authors include John W. Haycock, William F. Bennett, J. C. Waymire, H.V. Rickenberg, Ben H. Leichtling, Irene Majerfeld, Jerry Nedelman, Eva Spitz, James L. McGaugh and Gerard F. Cooney and has published in prestigious journals such as Journal of Biological Chemistry, Brain Research and Life Sciences.

In The Last Decade

John A. Meligeni

17 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John A. Meligeni United States 12 225 184 115 107 78 17 622
Anke C. Schiedel Germany 21 713 3.2× 272 1.5× 7 0.1× 60 0.6× 9 0.1× 47 1.2k
James M. Reynolds United States 18 319 1.4× 163 0.9× 3 0.0× 39 0.4× 149 1.9× 37 1.0k
H. Nau Germany 20 500 2.2× 146 0.8× 5 0.0× 38 0.4× 661 8.5× 37 1.4k
Verónica Milesi Argentina 16 622 2.8× 165 0.9× 4 0.0× 22 0.2× 46 0.6× 55 946
M. Fountoulakis Switzerland 18 907 4.0× 84 0.5× 4 0.0× 127 1.2× 19 0.2× 24 1.3k
Fernando Soler Spain 14 353 1.6× 89 0.5× 14 0.1× 44 0.4× 2 0.0× 47 611
Ralf Fliegert Germany 21 482 2.1× 97 0.5× 3 0.0× 52 0.5× 32 0.4× 43 1.4k
Raymond R. Brown United States 16 262 1.2× 57 0.3× 3 0.0× 18 0.2× 17 0.2× 30 990
Robert Chott United States 10 329 1.5× 105 0.6× 4 0.0× 20 0.2× 13 0.2× 15 1.0k
Hans P. Baer Canada 14 319 1.4× 123 0.7× 2 0.0× 20 0.2× 48 0.6× 43 624

Countries citing papers authored by John A. Meligeni

Since Specialization
Citations

This map shows the geographic impact of John A. Meligeni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Meligeni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Meligeni more than expected).

Fields of papers citing papers by John A. Meligeni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Meligeni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Meligeni. The network helps show where John A. Meligeni may publish in the future.

Co-authorship network of co-authors of John A. Meligeni

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Meligeni. A scholar is included among the top collaborators of John A. Meligeni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Meligeni. John A. Meligeni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Dunn, Stephen P., et al.. (1997). Reduced cyclosporine absorption preceded acute allograft rejection in a child with a liver transplant. Liver Transplantation and Surgery. 3(5). 538–540. 5 indexed citations
2.
Nedelman, Jerry, et al.. (1997). Description of Blood Pressure Changes in Patients Beginning Cyclosporin A Therapy. Therapeutic Drug Monitoring. 19(1). 17–24. 7 indexed citations
3.
Nedelman, Jerry, Ekaterina Gibiansky, Jeffrey A. Cramer, et al.. (1997). Multiple-dose pharmacokinetics of a long half-life drug: contributions of mathematical modeling. European Journal of Drug Metabolism and Pharmacokinetics. 22(2). 179–184. 2 indexed citations
4.
Nedelman, Jerry, Jeffrey A. Cramer, Bruce A. Robbins, et al.. (1997). THE EFFECT OF FOOD ON THE PHARMACOKINETICS OF MULTIPLE-DOSE TERBINAFINE IN YOUNG AND ELDERLY HEALTHY SUBJECTS. Biopharmaceutics & Drug Disposition. 18(2). 127–138. 25 indexed citations
5.
Robbins, Bruce A., et al.. (1996). Safe coadministration of terbinafine and terfenadine: A placebo-controlled crossover study of pharmacokinetic and pharmacodynamic interactions in healthy volunteers. Clinical Pharmacology & Therapeutics. 59(3). 275–283. 17 indexed citations
6.
Nedelman, Jerry, Ekaterina Gibiansky, Bruce A. Robbins, et al.. (1996). Pharmacokinetics and Pharmacodynamics of Multiple‐Dose Terbinafine. The Journal of Clinical Pharmacology. 36(5). 452–461. 20 indexed citations
7.
Barone, Gary W., Miles G. Choc, Jon B. Klein, et al.. (1996). THE PHARMACOKINETICS OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN PRIMARY RENAL ALLOGRAFT RECIPIENTS1. Transplantation. 61(6). 875–880. 82 indexed citations
8.
Cooney, Gerard F., B L Lum, John A. Meligeni, & Stephen P. Dunn. (1996). Pharmacokinetics of a microemulsion formulation of cyclosporine in pediatric liver transplant recipients.. PubMed. 28(4). 2270–2. 11 indexed citations
9.
Dunn, Stephen P., et al.. (1995). ABSORPTION CHARACTERISTICS OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN DE NOVO PEDIATRIC LIVER TRANSPLANT RECIPIENTS1,2. Transplantation. 60(12). 1438–1442. 39 indexed citations
10.
Chang, Cheng‐Tao, Jerry Nedelman, Albert Cohen, et al.. (1995). Efficacy and Pharmacokinetics of Two Formulations of Cyclosporine A in Patients with Psoriasis. The Journal of Clinical Pharmacology. 35(9). 865–875. 31 indexed citations
11.
Sallas, William M., et al.. (1995). A nonlinear mixed-effects pharmacokinetic model comparing two formulations of cyclosporine in stable renal transplant patients. Journal of Pharmacokinetics and Biopharmaceutics. 23(5). 495–514. 6 indexed citations
12.
Majerfeld, Irene, Ben H. Leichtling, John A. Meligeni, Eva Spitz, & H.V. Rickenberg. (1984). A cytosolic cyclic AMP-dependent protein kinase in Dictyostelium discoideum. I. Properties.. Journal of Biological Chemistry. 259(1). 654–661. 56 indexed citations
13.
Tank, A. William, John A. Meligeni, & N. Weiner. (1984). Cyclic AMP-dependent protein kinase is not involved in the in vivo activation of tyrosine hydroxylase in the adrenal gland after decapitation.. Journal of Biological Chemistry. 259(14). 9269–9276. 20 indexed citations
14.
Haycock, John W., John A. Meligeni, William F. Bennett, & J. C. Waymire. (1982). Phosphorylation and activation of tyrosine hydroxylase mediate the acetylcholine-induced increase in catecholamine biosynthesis in adrenal chromaffin cells.. Journal of Biological Chemistry. 257(21). 12641–12648. 97 indexed citations
15.
Meligeni, John A., John W. Haycock, William F. Bennett, & J. C. Waymire. (1982). Phosphorylation and activation of tyrosine hydroxylase mediate the cAMP-induced increase in catecholamine biosynthesis in adrenal chromaffin cells.. Journal of Biological Chemistry. 257(21). 12632–12640. 166 indexed citations
16.
Meligeni, John A., et al.. (1978). Norepinephrine attenuation of amnesia produced by diethyldithiocarbamate. Brain Research. 149(1). 155–164. 30 indexed citations
17.
Haycock, John W. & John A. Meligeni. (1977). Neurotransmitter accumulation and calcium-dependent release from different regions of rat brain. Life Sciences. 21(12). 1837–1843. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anke C. Schiedel Breakdown of academic impact, for papers by James M. Reynolds Breakdown of academic impact, for papers by H. Nau Breakdown of academic impact, for papers by Verónica Milesi Breakdown of academic impact, for papers by M. Fountoulakis Breakdown of academic impact, for papers by Fernando Soler Breakdown of academic impact, for papers by Ralf Fliegert Breakdown of academic impact, for papers by Raymond R. Brown Breakdown of academic impact, for papers by Robert Chott Breakdown of academic impact, for papers by Hans P. Baer
Rankless by CCL
2026